ConductScience.org, home

Paper42723950

Longitudinal analysis of genomic and immune differences between primary and metastatic nasopharyngeal carcinoma for precision oncology.

Lu Y and 7 others. Front Oncol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Longitudinal analysis of genomic and immune differences between primary and metastatic nasopharyngeal carcinoma for precision oncology. Papers, record 42723950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42723950

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Longitudinal analysis of genomic and immune differences between primary and metastatic nasopharyngeal carcinoma for precision oncology.
PubMed
Journal
Front Oncol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-12
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lu YYing
2Han TTiantian
3Wang LLihui
4Chen XXishan
5Lin HHuan
6Wang MMengxiao
7Chen DDongsheng
8Huang HHaixin

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140244574Atezolizumab and Trastuzumab Plus Chemotherapy for ERBB2-Positive Locally Advanced Resectable Gastric Cancer: A Randomized Clinical Trial.JAMA Oncol2025https://conductscience.org/library/papers/40244574PubMed
219153016Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging.Int J Radiat Oncol Biol Phys2009https://conductscience.org/library/papers/19153016PubMed
332284611CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption.Nat Med2020https://conductscience.org/library/papers/32284611PubMed
441002563Tumor Immune Microenvironment and Current Status of Immune Checkpoint Inhibitor Therapy in Colorectal Cancer Liver Metastasis.Curr Oncol2025https://conductscience.org/library/papers/41002563PubMed
538755255Immunotherapy for recurrent or metastatic nasopharyngeal carcinoma.NPJ Precis Oncol2024https://conductscience.org/library/papers/38755255PubMed
628098136Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations.Nat Commun2017https://conductscience.org/library/papers/28098136PubMed
728060369Virus-associated neoplasms of the nasopharynx and sinonasal tract: diagnostic problems.Mod Pathol2017https://conductscience.org/library/papers/28060369PubMed
817060483Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology.Ann Oncol2007https://conductscience.org/library/papers/17060483PubMed
933531485Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution.Nat Commun2021https://conductscience.org/library/papers/33531485PubMed
1034234122Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape.Nat Commun2021https://conductscience.org/library/papers/34234122PubMed
1112721548Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population.Nat Genet2003https://conductscience.org/library/papers/12721548PubMed
1232853711Development of a Prognostic Model to Identify the Suitable Definitive Radiation Therapy Candidates in de Novo Metastatic Nasopharyngeal Carcinoma: A Real-World Study.Int J Radiat Oncol Biol Phys2021https://conductscience.org/library/papers/32853711PubMed
1338473280Precision Medicine for Nasopharyngeal Cancer-A Review of Current Prognostic Strategies.Cancers (Basel)2024https://conductscience.org/library/papers/38473280PubMed
1440209143Updates on Treatments and Management of Nasopharyngeal Carcinoma.Am Soc Clin Oncol Educ Book2025https://conductscience.org/library/papers/40209143PubMed
1531178151Nasopharyngeal carcinoma.Lancet2019https://conductscience.org/library/papers/31178151PubMed
1632983126Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment.Front Immunol2020https://conductscience.org/library/papers/32983126PubMed
1729933636Genomic Landscapes of EBV-Associated Nasopharyngeal Carcinoma vs. HPV-Associated Head and Neck Cancer.Cancers (Basel)2018https://conductscience.org/library/papers/29933636PubMed
1838254110Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes.Mol Cancer2024https://conductscience.org/library/papers/38254110PubMed
1937188668Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma.Nat Commun2023https://conductscience.org/library/papers/37188668PubMed
2040513067Anti-angiogenic therapy combined with immune checkpoint blockade mediates CCR7 + CD8 + T-cell entry into HCC through high endothelial venules.Hepatology2026https://conductscience.org/library/papers/40513067PubMed

See all 35 referencesDownload CSV of references

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
IDO13620PubTator's text mininghttps://conductscience.org/library/genes/3620NCBI Gene
MYC4609PubTator's text mininghttps://conductscience.org/library/genes/4609NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42723950

GET https://conductscience.org/api/papers/v1/42723950/references?page=2